RESUMEN
A TiO2 strip array with a thickness of 90 nm was fabricated by photolithography and physical vapor deposition. This work utilized the chemical and physical methods to fabricate the TiO2 strip array. A porous semiconductor layer made of TiO2 nanoparticles was coated on the TiO2 strip array. The TiO2 strip array has a one-dimensional protrusive structure. The energy conversion efficiency (4.38%) of a dye-sensitized solar cell (DSSC) with the TiO2 strip array exceeded that (3.20%) of a DSSC without a TiO2 strip array by 37%. In addition, this result was verified by the electrochemical impedance spectra of the two DSSCs. Therefore, the TiO2 strip array can be used to increase the energy conversion efficiencies of DSSCs. The large energy conversion efficiency of the DSSC with the TiO2 strip array arises from the large surface area of the one-dimensional protrusive structure and its specific electron transport paths. The DSSC with the TiO2 strip array has advantages of economical production cost, easy fabrication, and boosting energy conversion efficiency.
RESUMEN
A simple method that is compatible with all geometrical structures of terahertz (THz) metamaterials for increasing their frequency tunabilities and decreasing their operating electric fields is proposed. This method uses the displacement of glycerol droplets with various volumes to tune the resonance frequency of a THz metamaterial in an electrowetting-on-dielectric (EWOD) cell. The experimental results reveal that the THz metamaterial has a large frequency tunability of 28% at an operating electric field that is smaller than 0.2 V/µm as the glycerol droplets move in and out of the path of a THz beam. The frequency tunability is large because the near field of the metamaterial "experiences" a large difference between the refractive indices of glycerol and air. The EWOD cell with the THz metamaterial is a great achievement for developing electrically controllable band-stop filters with large frequency tunabilities and small operating electric fields.
RESUMEN
Sodium arsenite (arsenite)-induced neurotoxicity and its interaction with ferrous citrate (iron) was investigated in rat brain. In vitro data showed that arsenite (1-10 micromol/L) concentration dependently increased lipid peroxidation and the potency of arsenite was less than that of iron. The oxidative activity of arsenite, sodium arsenate (arsenate), monomethylarsonic acid (MMA), and dimethylarsinic acid (DMA) were evaluated by inducing lipid peroxidation in cortical homogenates, and the potency for this effect was as follows: arsenite > arsenate > MMA and DMA. Several well-known antioxidants, including glutathione, melatonin, and beta-estradiol inhibited arsenite-induced lipid peroxidation in a concentration-dependent manner. Our in vivo study employed intranigral infusion of arsenite (5 nmol) in the substantia nigra (SN) of anesthetized rats. Four hours to 7 days after infusion, lipid peroxidation was elevated while glutathione was depleted in the infused SN. The dopamine content in the striatum ipsilateral to arsenite-infused SN was first elevated 24 h and then decreased 7 days after intranigral infusion of arsenite. Using pretreatment of l-buthionine-[S,R]-sulfoximine (l-BSO, i.c.v.) to reduce glutathione content in rat brain, arsenite-induced oxidative injury was augmented. Low doses of arsenite (1.5 nmol) and iron (3 nmol) alone induced minimal oxidative injury; however, co-infusion of arsenite and iron augmented neurotoxicity, including elevated lipid peroxidation and reduced striatal dopamine content. Moreover, expression of heme oxygenase-1, alpha-synuclein aggregation, and DNA fragmentation were significantly enhanced in SN co-infused with low doses of arsenite and iron. Taken together, our study demonstrates that arsenite was less potent than iron in inducing oxidative stress. Furthermore, concomitant arsenite and iron potentiated oxidative injury in the nigrostriatal dopaminergic system, indicating that interaction of metals plays a more clinically-relevant role in pathophysiology of central nervous system neurodegeneration.
Asunto(s)
Arsenitos/toxicidad , Lesiones Encefálicas/inducido químicamente , Hierro/administración & dosificación , Peroxidación de Lípido/efectos de los fármacos , Animales , Western Blotting , Lesiones Encefálicas/metabolismo , Butionina Sulfoximina/administración & dosificación , Cromatografía Líquida de Alta Presión , Dopamina/metabolismo , Sinergismo Farmacológico , Electroquímica , Glutatión/metabolismo , Hemo Oxigenasa (Desciclizante)/metabolismo , Masculino , Ratas , Ratas Sprague-Dawley , Espectrometría de Fluorescencia , Sustancia Negra/enzimología , Sustancia Negra/metabolismo , alfa-Sinucleína/metabolismoRESUMEN
BACKGROUND: The overexpression of Ck19 antigen occurs frequently in human carcinomas. The strategy and mechanism of radioimmunotherapy using Re-188-mAbCx-99 to Ck19 on human cervical carcinoma cells was investigated in this study. MATERIALS AND METHODS: Using mAbCx-99, the overexpression of Ck19 protein in lysates of cell lines and tissues from various patients' cervixes were verified by immunobinding and immunoblot analysis. The therapeutic effect of Re-188-mAbCx-99 on ME180 cells was examined in vitro by cell proliferation, apoptosis, DNA fragmentation and intemucleosomal levels. RESULTS: A relatively high expression of Ck19 was found in all human cervical carcinoma cell lines (4- to 44-fold) and in tissue lysates (26.8- to 79-fold) from patients (31 out of 34) with cervical, endometrial or ovarian carcinomas compared with that of benign or normal control samples. The growth inhibition of ME180, CC7T and Hela cells were significantly higher (p < 0.001) in the Re-188-mAbCx-99-treated (60-80%) than in the Re-188-MOPCIgG1-treated lines (8-18%) after 72-h treatment. After 48 h of treatment with Re-188-mAbCx-99, ME180 cells significantly exhibited DNA fragmentation and morphological features of apoptosis. This effect markedly elevated the expression of p21, p53 and Bcl-xS protein, while the Mcl-1 and Caspase-8 proteins were down-regulated. CONCLUSION: We suggest that an elevated Ck19 level is associated with disease stage in most patients with cervical cancer. The therapeutic effect of Re-188-mAbCx-99 was verified through apoptosis on targeting the enriched Ck19 protein of carcinoma cells.
Asunto(s)
Carcinoma de Células Escamosas/radioterapia , Inmunotoxinas/farmacología , Queratinas/biosíntesis , Radioinmunoterapia/métodos , Radioisótopos/farmacología , Renio/farmacología , Neoplasias del Cuello Uterino/radioterapia , Anticuerpos Monoclonales/inmunología , Anticuerpos Monoclonales/farmacología , Especificidad de Anticuerpos , Apoptosis/efectos de la radiación , Carcinoma de Células Escamosas/inmunología , Carcinoma de Células Escamosas/metabolismo , Carcinoma de Células Escamosas/patología , Proteínas de Ciclo Celular/biosíntesis , Procesos de Crecimiento Celular/efectos de la radiación , Línea Celular Tumoral , Inhibidor p21 de las Quinasas Dependientes de la Ciclina , Femenino , Células HeLa , Humanos , Queratinas/inmunología , Nucleosomas/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2/biosíntesis , Proteínas Proto-Oncogénicas c-jun/biosíntesis , Proteína p53 Supresora de Tumor/biosíntesis , Neoplasias del Cuello Uterino/inmunología , Neoplasias del Cuello Uterino/metabolismo , Neoplasias del Cuello Uterino/patologíaRESUMEN
A high-molecular-weight mite allergen Der f11 that was hardly purified for immunotherapy was used to develop the DNA vaccine pDf11. We have shown that vaccination of mice with pDf11 induces Th1 responses characterized by suppression of IgE responses. In the present study, effects of different adjuvants on pDf11 were first studied. Mice receiving pDf11 +/- CpG, bestatin, and bupivacaine had better suppression of IgE responses than those receiving pDf11 +/- lipofectin or alum. Bestatin could greatly boost IgG2a responses. Immunomodulating effects of different adjuvants between protein and DNA vaccines were further elucidated. CpG was the best for both protein and DNA vaccines to profoundly suppress IgE responses, but alum, bestatin and lipofectin were useless for rDf11 to induce IgE inhibition. Neither did the combination of rDf11 and pDf11 have further IgE suppression. In conclusion, CpG is the unique adjuvant for the protein vaccine rDf11 to inhibit IgE responses. In contrast, the DNA vaccine pDf11 +/- CpG, bestatin, or bupivacaine induces profound suppression of IgE responses.
Asunto(s)
Adyuvantes Inmunológicos/farmacología , Inmunoglobulina E/biosíntesis , Leucina/análogos & derivados , Vacunas de ADN/inmunología , Vacunas de Subunidad/inmunología , Alérgenos/inmunología , Compuestos de Alumbre/farmacología , Animales , Química Farmacéutica , Islas de CpG/efectos de los fármacos , Femenino , Inmunoglobulina E/análisis , Inmunoglobulina G/análisis , Inmunoglobulina G/biosíntesis , Leucina/farmacología , Ratones , Ratones Endogámicos BALB C , Ácaros/inmunología , Fosfatidiletanolaminas/farmacología , Plásmidos/inmunología , Ratas , Ratas Sprague-DawleyRESUMEN
DNA vaccines encoding low-molecular-weight allergens have been used to prevent IgE responses. A high-molecular-weight mite allergen Der f 11 that was hardly to be purified for immunotherapy was used to develop a DNA vaccine here. Vaccination of mice with plasmid DNA encoding Df11 (pDf11) induced Th1 responses characterized by IgG2a responses and spleen cell secretion of IFN-gamma. In contrast, sensitization with recombinant Der f 11 (rDf11) and alum induced Th2 responses characterized by IgE responses and spleen cell secretion of IL-4 and IL-5. Vaccination with pDf11 prevented the induction of IgE responses. Moreover, it could inhibit on-going IgE responses. The debate whether CD4+ or CD8+ T cells were the regulatory cells to inhibit IgE responses by DNA vaccination was also examined. First, sensitization of pDf11-vaccinated mice after depletion of CD8+ T cells still showed suppression of IgE responses. Secondly, adoptive transfer of either CD4- or CD8-depleted spleen cells from pDf11-vaccinated mice suppressed IgE responses. In conclusion, this is the first report to confirm the therapeutic effect of a DNA vaccine encoding a strong allergen on specific IgE responses. Both CD4+ and CD8+ T cells are crucial for the immunomodulation of IgE responses by pDf11.